DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Antroquinonol is an investigational drug.
There have been 9 clinical trials for Antroquinonol. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2013.
The most common disease conditions in clinical trials are Eczema, Dermatitis, Atopic, and Dermatitis. The leading clinical trial sponsors are Golden Biotechnology Corporation, Cheng-Chung Wei, and Chung Shan Medical University.
There are two US patents protecting this investigational drug and eighteen international patents.
Recent Clinical Trials for Antroquinonol
|Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients||Golden Biotechnology Corporation||Phase 2|
|A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B||Golden Biotechnology Corporation||Phase 2|
|A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B||Cheng-Chung Wei||Phase 2|
Top disease conditions for Antroquinonol
Top clinical trial sponsors for Antroquinonol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Antroquinonol||Start Trial||Methods and compositions for treating leukemia||Golden Biotechnology Corporation (Jersey City, NJ)||Start Trial|
|Antroquinonol||Start Trial||Compounds from antrodia camphorate and their use in treatment of diabetes mellitus||National Dong Hwa University (Hualien, TW)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|